Executive Director, Biologics Process Development

Merck & Co. is seeking an accomplished, motivated Executive Director of Biologics Process Development to join our team. This is an exciting opportunity to take the lead on the development and optimization of biologics processes to ensure they are in compliance with Merck's standards and best practices. The successful candidate will bring extensive experience in biologics process development, a deep understanding of the regulations and guidelines governing biologics, and a passion for driving innovation and excellence in process development. We seek a leader with experience in the biologics industry and a proven track record of leading process development teams. The ideal candidate will have a Ph.D. in a relevant field and at least 10 years of relevant experience in biologics process development, including hands-on experience with bioreactors, chromatography, and other process development techniques. We require excellent communication skills, the ability to effectively manage a team, and a commitment to driving collaboration between departments and external partners.

According to JobzMall, the average salary range for a Executive Director, Biologics Process Development in Rahway, NJ 07065, USA is between $150,000 and $250,000 per year. This range is based on salaries reported by JobzMall users and third party data sources. The salary range can vary depending on factors such as the employer, level of experience, and other qualifications.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.